Xarelto and Seroma - a phase IV clinical study of FDA data

Summary:

Seroma is reported as a side effect among people who take Xarelto (rivaroxaban), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zejula, and have Abnormal faeces.

The phase IV clinical study analyzes which people have Seroma when taking Xarelto. It is created by eHealthMe based on reports of 210,230 people who have side effects when taking Xarelto from the FDA, and is updated regularly.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,377 Xarelto users. Check the latest studies of Xarelto.

What is Seroma?

Seroma (a tumour like collection of serum in the tissues) is found to be associated with 333 drugs and 399 conditions by eHealthMe. Check the latest studies of Seroma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

210,230 people reported to have side effects when taking Xarelto.
Among them, 28 people (0.01%) have Seroma.

Among these 28 people:

How long have people been on Xarelto when they have Seroma? *

What is the gender of people who have Seroma when taking Xarelto? *

female: 78.26 %
male: 21.74 %

What is the age of people who have Seroma when taking Xarelto? *

What are other drugs people take besides Xarelto? *

What are other side effects people have besides Seroma? *

Haematoma (collection of blood outside the blood vessels): 8 people, 28.57%
Nausea (feeling of having an urge to vomit): 7 people, 25.00%
Red Blood Cell Count Decreased: 5 people, 17.86%
Rashes (redness): 4 people, 14.29%
Nosebleed (bleeding from nose): 4 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 4 people, 14.29%
Dizziness: 4 people, 14.29%
Pain: 4 people, 14.29%
Mouth Haemorrhage (bleeding from mouth): 4 people, 14.29%
Pelvic Mass: 4 people, 14.29%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 3 people, 10.71%
Pain: 3 people, 10.71%
Migraine (headache): 3 people, 10.71%
Astrocytoma, Low Grade (low grade tumour of the brain that originate in a particular kind of glial-cells): 3 people, 10.71%
Angiomyolipoma (most common benign tumour of the kidney): 3 people, 10.71%
Abnormal Faeces (abnormal stool): 3 people, 10.71%
Ill-Defined Disorder: 2 people, 7.14%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.57%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 3.57%
Osteoporosis (bones weak and more likely to break): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Xarelto and have Seroma?

- Check whether Seroma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xarelto:

Xarelto (212,377 reports)

Seroma treatments and more:

Seroma (2,095 reports)

Browse all side effects of Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Seroma:

Seroma (333 drugs)

Browse all the conditions that are associated with Seroma:

Seroma (399 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Xarelto) and Xarelto (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.